Institution-Grade Tools, Priced for Individual Investors.
Receive trading alerts directly to your inbox. Try Barchart Plus or Barchart Premier for free today.
/Marriott%20International%2C%20Inc_%20hotel%20by-%20yujie%20chen%20via%20iStock.jpg)
/Northrop%20Grumman%20Corp_%20website%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
Markets enter March following another losing week that saw airline stocks hammered after President Trump's threats against Iran escalated Middle East tensions, while a surprisingly hot inflation reading...
With impressive, significant gains, could Canadian electronic component supplier Celestica have more room to run?
While unusual options activity may be the dominant screener in the options world, volatility skew deserves some love due to its structural intelligence.
/AI%20(artificial%20intelligence)/AI%20software%20engineering%20by%20Tapati%20Rinchumrus%20via%20Shutterstock.jpg)
This multibagger AI stock has received a "Buy" rating and price upgrade from a Citi analyst with strong support on Wall Street.
Okta shares have tumbled amid AI-fueled volatility despite bold upside forecasts. Can investors capitalize on the dislocation before sentiment turns?
Agentic AI fears have knocked LegalZoom down nearly 30% in 2026. Is this a buy-the-dip opportunity for investors?
/The%20DocuSign%20headquarters%20by%20Tada%20Images%20via%20Shutterstock.jpg)
Even after a steep pullback, DocuSign could surge over 170% if it hits the $124 Street-high target set by Citizens, indicating a bold turnaround call.
Berkshire Hathaway will release its 2025 annual report and Greg Abel’s first CEO letter on Feb. 28.
/Regeneron%20Pharmaceuticals%2C%20Inc_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Although Regeneron Pharmaceuticals has lagged the Nasdaq over the past year, analysts remain highly bullish about its prospects.
Summary The Travelers Companies (TRV) demonstrates strong technical momentum, with a Trend Seeker 'Buy' signal and 9.54% gain over the past month. TRV trades at an 11.01x trailing P/E, notably below the...
